Complete Filing Data
Candel Therapeutics, Inc. reported Stockholders Equity of $51.92 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Candel Therapeutics, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Income * | -$38.2M | -$55.2M | -$37.9M | -$18.8M | -$36.1M | -$17.7M |
| Research And Development Expense | $30.5M | $19.3M | $24.5M | $20.8M | $15.2M | $8.8M |
| Operating Income Loss | -$48.3M | -$33.4M | -$38.4M | -$34.7M | -$25.7M | -$13.8M |
| Operating Expenses | $48.3M | $33.4M | $38.4M | $34.8M | $25.9M | $13.9M |
| Nonoperating Income Expense | $10.1M | -$21.8M | $452.0K | $15.9M | -$10.4M | -$3.9M |
| General And Administrative Expense | $17.8M | $14.1M | $13.9M | $14.1M | $10.7M | $5.2M |
| Non Cash Interest Expense | $138.0K | $119.0K | $103.0K | $89.0K | $76.0K | $32.0K |
| Nonoperating Gains Losses | $89.0K | $48.0K | $1.1M | $624.0K | ||
| Revenue From Contract With Customer Excluding Assessed Tax | $125.0K | $125.0K | $125.0K | |||
| Income Taxes Paid Net | $183.0K | $29.0K | $93.0K | |||
| Interest Expense | $2.6M | $1.7M | ||||
| Deferred Revenue Noncurrent | $89.0K | $0.00 | $144.0K | $125.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$11.3M | -$4.8M | $7.4M | -$10.6M | -$22.2M | -$8.2M | -$8.4M | -$9.6M | -$8.8M | -$8.7M | -$4.1M | -$874.0K | -$16.2M | -$17.1M | -$4.5M | -$2.6M | -$2.9M |
| Research And Development Expense | $8.5M | $7.0M | $4.0M | $5.4M | $5.0M | $4.1M | $5.8M | $5.9M | $5.5M | $5.4M | $5.0M | $5.4M | $5.3M | $3.3M | $2.8M | $1.8M | $1.8M |
| Operating Income Loss | -$13.2M | -$11.2M | -$8.1M | -$8.8M | -$8.6M | -$7.9M | -$8.9M | -$9.6M | -$9.6M | -$8.9M | -$8.8M | -$9.0M | -$8.0M | -$5.3M | -$4.7M | -$2.7M | -$2.6M |
| Operating Expenses | $13.2M | $11.2M | $8.1M | $8.8M | $8.6M | $7.9M | $8.9M | $9.6M | $9.6M | $8.9M | $8.8M | $9.0M | $8.1M | $5.3M | $4.7M | $2.8M | $2.7M |
| Nonoperating Income Expense | $1.9M | $6.4M | $15.5M | -$1.9M | -$13.7M | -$319.0K | $426.0K | -$35.0K | $838.0K | $193.0K | $4.6M | $8.1M | -$8.1M | -$11.8M | $179.0K | $195.0K | -$257.0K |
| General And Administrative Expense | $4.7M | $4.2M | $4.1M | $3.3M | $3.6M | $3.8M | $3.0M | $3.6M | $4.2M | $3.5M | $3.8M | $3.6M | $2.8M | $2.0M | $1.9M | $967.0K | $855.0K |
| Non Cash Interest Expense | $34.0K | $30.0K | $26.0K | $22.0K | $20.0K | ||||||||||||
| Nonoperating Gains Losses | $12.0K | $12.0K | $12.0K | $131.0K | $605.0K | $191.0K | $154.0K | $156.0K | |||||||||
| Revenue From Contract With Customer Excluding Assessed Tax | $31.0K | $31.0K | $31.0K | $31.0K | $31.0K | $31.0K | $31.0K | $31.0K | |||||||||
| Income Taxes Paid Net | $85.0K | $6.0K | |||||||||||||||
| Interest Expense | $487.0K | $567.0K | $646.0K | $669.0K | $644.0K | $609.0K | $519.0K | $435.0K | |||||||||
| Deferred Revenue Noncurrent | $108.0K | $120.0K | $132.0K | $31.0K | $63.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity | $51.9M | $66.3M | $12.7M | $47.7M | $64.1M | -$23.6M | -$8.0M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $120.1M | $102.9M | $35.7M | $70.3M | $83.1M | $35.3M | $5.4M |
| Retained Earnings Accumulated Deficit | -$230.4M | -$192.2M | -$137.0M | -$99.1M | -$80.3M | -$44.2M | |
| Property Plant And Equipment Net | $1.6M | $2.2M | $3.2M | $4.4M | $3.8M | $2.8M | |
| Prepaid Expense And Other Assets Current | $1.7M | $1.2M | $1.4M | $1.9M | $2.3M | $93.0K | |
| Liabilities Current | $9.0M | $37.5M | $14.2M | $5.6M | $5.4M | $4.7M | |
| Liabilities And Stockholders Equity | $125.2M | $106.9M | $41.2M | $77.7M | $89.2M | $38.3M | |
| Liabilities | $73.3M | $40.5M | $28.5M | $30.0M | $25.1M | $12.8M | |
| Common Stock Value | $550.0K | $469.0K | $290.0K | $290.0K | $286.0K | $116.0K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $17.2M | $67.2M | -$34.6M | -$12.7M | $47.7M | $29.9M | |
| Cash And Cash Equivalents At Carrying Value | $119.7M | $102.7M | $35.4M | $70.1M | $82.6M | $35.1M | |
| Assets Current | $121.4M | $103.8M | $36.8M | $71.9M | $84.9M | $35.1M | |
| Assets | $125.2M | $106.9M | $41.2M | $77.7M | $89.2M | $38.3M | |
| Additional Paid In Capital Common Stock | $282.2M | $258.5M | $149.9M | $147.0M | $144.1M | $20.5M | |
| Accrued Liabilities Current | $7.3M | $5.1M | $4.4M | $4.7M | $3.4M | $3.1M | |
| Accounts Payable Current | $1.1M | $237.0K | $422.0K | $380.0K | $1.6M | $921.0K | |
| Warrant Liability Noncurrent | $15.6M | $0.00 | $916.0K | $1.9M | $18.3M | $6.8M | |
| Restricted Cash Noncurrent | $416.0K | $266.0K | $266.0K | $266.0K | $424.0K | ||
| Other Long Term Debt Noncurrent | $1.0M | $870.0K | $751.0K | $648.0K | $560.0K | ||
| Operating Lease Right Of Use Asset | $1.7M | $542.0K | $816.0K | $1.1M | |||
| Operating Lease Liability Noncurrent | $1.5M | $407.0K | $973.0K | $1.5M | |||
| Operating Lease Liability Current | $445.0K | $566.0K | $513.0K | $464.0K | |||
| Non Cash Lease Expense | $321.0K | $274.0K | $240.0K | $209.0K | |||
| Accretion Of Debt Discount | $360.0K | $270.0K | $323.0K | $291.0K | |||
| Treasury Stock Value | $448.0K | $448.0K | $448.0K | $448.0K | |||
| Other Liabilities Current | $89.0K | $0.00 | $48.0K | $334.0K | $187.0K | ||
| Long Term Debt Current | $0.00 | $9.9M | $8.9M | ||||
| Other Assets | $87.0K | $63.0K | $116.0K | ||||
| Gain Loss On Disposition Of Assets1 | -$306.0K | $0.00 | -$79.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $80.1M | $90.2M | $74.7M | -$15.3M | -$10.0M | $6.0M | $23.0M | $30.8M | $39.7M | $52.1M | $60.1M | $63.8M | $63.0M | -$43.2M | -$27.5M | -$14.8M | -$12.3M | -$10.1M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $87.2M | $101.0M | $92.4M | $16.8M | $21.7M | $26.0M | $43.2M | $52.2M | $59.5M | $77.4M | $87.0M | $94.8M | $88.8M | $24.7M | $29.6M | $18.5M | $20.8M | |
| Retained Earnings Accumulated Deficit | -$200.9M | -$189.6M | -$184.8M | -$178.1M | -$167.5M | -$145.2M | -$125.9M | -$117.5M | -$107.9M | -$94.0M | -$85.3M | -$81.2M | -$81.9M | -$65.7M | ||||
| Property Plant And Equipment Net | $1.4M | $1.7M | $2.0M | $2.5M | $2.7M | $3.0M | $3.7M | $4.0M | $4.1M | $4.6M | $4.5M | $4.3M | $4.6M | $4.6M | ||||
| Prepaid Expense And Other Assets Current | $3.2M | $2.9M | $983.0K | $1.5M | $1.3M | $1.4M | $2.1M | $1.5M | $2.6M | $1.9M | $544.0K | $1.3M | $2.6M | $110.0K | ||||
| Liabilities Current | $10.9M | $14.7M | $20.1M | $15.3M | $14.0M | $13.5M | $10.3M | $8.2M | $5.2M | $5.9M | $5.9M | $5.5M | $4.4M | $4.5M | ||||
| Liabilities And Stockholders Equity | $93.6M | $106.0M | $95.9M | $21.5M | $26.5M | $31.2M | $50.1M | $58.7M | $67.2M | $85.0M | $93.3M | $101.6M | $96.0M | $30.7M | ||||
| Liabilities | $13.5M | $15.8M | $21.2M | $36.8M | $36.5M | $25.2M | $27.0M | $27.9M | $27.6M | $32.9M | $33.2M | $37.8M | $33.0M | $24.9M | ||||
| Common Stock Value | $550.0K | $549.0K | $493.0K | $322.0K | $303.0K | $292.0K | $290.0K | $290.0K | $290.0K | $290.0K | $290.0K | $287.0K | $286.0K | $117.0K | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$10.5M | -$9.7M | -$10.8M | $11.7M | -$5.7M | |||||||||||||
| Cash And Cash Equivalents At Carrying Value | $87.0M | $100.7M | $92.2M | $16.6M | $21.5M | $25.7M | $43.0M | $51.9M | $59.3M | $77.2M | $86.8M | $94.3M | $88.4M | $24.3M | ||||
| Assets Current | $90.1M | $103.6M | $93.1M | $18.1M | $22.7M | $27.1M | $45.1M | $53.4M | $61.9M | $79.1M | $87.3M | $95.6M | $91.0M | $24.4M | ||||
| Assets | $93.6M | $106.0M | $95.9M | $21.5M | $26.5M | $31.2M | $50.1M | $58.7M | $67.2M | $85.0M | $93.3M | $101.6M | $96.0M | $30.7M | ||||
| Additional Paid In Capital Common Stock | $280.9M | $279.7M | $259.5M | $163.0M | $157.7M | $151.4M | $149.1M | $148.4M | $147.7M | $146.3M | $145.5M | $144.6M | $144.6M | $22.4M | ||||
| Accrued Liabilities Current | $5.1M | $4.3M | $2.7M | $4.6M | $3.2M | $2.8M | $3.4M | $3.5M | $2.9M | $4.4M | $3.8M | $3.6M | $3.2M | $3.5M | ||||
| Accounts Payable Current | $1.1M | $2.0M | $760.0K | $296.0K | $433.0K | $472.0K | $250.0K | $480.0K | $592.0K | $970.0K | $1.6M | $1.4M | $925.0K | $759.0K | ||||
| Warrant Liability Noncurrent | $15.9M | $14.2M | $909.0K | $433.0K | $1.0M | $1.2M | $4.6M | $5.0M | $10.0M | $27.5M | $19.2M | |||||||
| Restricted Cash Noncurrent | $266.0K | $266.0K | $266.0K | $266.0K | $266.0K | $266.0K | $266.0K | $266.0K | $266.0K | $266.0K | $266.0K | $437.0K | ||||||
| Other Long Term Debt Noncurrent | $973.0K | $939.0K | $904.0K | $840.0K | $810.0K | $781.0K | $725.0K | $700.0K | $674.0K | $626.0K | $604.0K | $582.0K | ||||||
| Operating Lease Right Of Use Asset | $1.8M | $391.0K | $468.0K | $614.0K | $684.0K | $751.0K | $879.0K | $940.0K | $999.0K | $1.1M | $1.2M | $1.2M | ||||||
| Operating Lease Liability Noncurrent | $1.6M | $104.0K | $257.0K | $555.0K | $698.0K | $837.0K | $1.1M | $1.2M | $1.4M | $1.6M | $1.7M | $1.8M | ||||||
| Operating Lease Liability Current | $437.0K | $594.0K | $580.0K | $552.0K | $539.0K | $526.0K | $500.0K | $488.0K | $476.0K | $452.0K | $440.0K | $429.0K | ||||||
| Non Cash Lease Expense | $74.0K | $65.0K | $57.0K | $50.0K | ||||||||||||||
| Accretion Of Debt Discount | $44.0K | $83.0K | $75.0K | $32.0K | ||||||||||||||
| Treasury Stock Value | $448.0K | $448.0K | $448.0K | $448.0K | $448.0K | $448.0K | $448.0K | $448.0K | $448.0K | $448.0K | $448.0K | |||||||
| Other Liabilities Current | $48.0K | $48.0K | $48.0K | $31.0K | $63.0K | $94.0K | $229.0K | $224.0K | ||||||||||
| Long Term Debt Current | $4.2M | $6.7M | $9.2M | $9.9M | $9.8M | $9.8M | $6.1M | $3.7M | $1.3M | |||||||||
| Other Assets | $85.0K | $45.0K | $58.0K | $75.0K | $81.0K | $102.0K | $139.0K | $159.0K | ||||||||||
| Gain Loss On Disposition Of Assets1 | -$300.0K | $0.00 | $0.00 | -$74.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Share Based Compensation | $3.8M | $5.3M | $3.1M | $2.3M | $3.0M | $2.1M |
| Payments To Acquire Property Plant And Equipment | $587.0K | $16.0K | $457.0K | $1.3M | $1.8M | $1.5M |
| Net Cash Provided By Used In Operating Activities | -$38.3M | -$27.0M | -$34.2M | -$31.4M | -$22.2M | -$9.1M |
| Net Cash Provided By Used In Investing Activities | -$560.0K | -$16.0K | -$280.0K | -$1.3M | -$1.8M | $38.5M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $508.0K | -$234.0K | -$503.0K | -$416.0K | $2.2M | -$60.0K |
| Increase Decrease In Accrued Liabilities | $2.3M | $757.0K | -$301.0K | $1.3M | $297.0K | $1.5M |
| Increase Decrease In Accounts Payable | $802.0K | -$185.0K | $45.0K | -$1.2M | $669.0K | $289.0K |
| Net Cash Provided By Used In Financing Activities | $56.1M | $94.3M | -$121.0K | $20.0M | $71.8M | $490.0K |
| Proceeds From Stock Options Exercised | $516.0K | $1.7M | $64.0K | $35.0K | $30.0K | |
| Increase Decrease In Contract With Customer Liability | $178.0K | -$192.0K | $67.0K | -$125.0K | -$125.0K | |
| Increase Decrease In Operating Lease Liability | -$509.0K | -$513.0K | -$464.0K | -$464.0K | ||
| Increase Decrease In Other Operating Assets | $24.0K | -$53.0K | $116.0K | |||
| Depreciation Depletion And Amortization | $778.0K | $232.0K | $91.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|
| Share Based Compensation | $314.0K | $1.0M | $733.0K | $492.0K | $431.0K |
| Payments To Acquire Property Plant And Equipment | $3.0K | $7.0K | $138.0K | $171.0K | $229.0K |
| Net Cash Provided By Used In Operating Activities | -$8.6M | -$8.4M | -$10.8M | -$8.1M | -$5.6M |
| Net Cash Provided By Used In Investing Activities | -$3.0K | -$7.0K | $19.0K | -$171.0K | -$229.0K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$167.0K | $39.0K | $730.0K | -$979.0K | $225.0K |
| Increase Decrease In Accrued Liabilities | -$2.4M | -$1.6M | -$1.8M | $90.0K | -$1.3M |
| Increase Decrease In Accounts Payable | $507.0K | $50.0K | $149.0K | -$579.0K | $173.0K |
| Net Cash Provided By Used In Financing Activities | -$1.9M | -$1.3M | $0.00 | $19.9M | $112.0K |
| Proceeds From Stock Options Exercised | $246.0K | $226.0K | $6.0K | $35.0K | |
| Increase Decrease In Contract With Customer Liability | $0.00 | -$12.0K | -$31.0K | -$31.0K | |
| Increase Decrease In Operating Lease Liability | -$136.0K | -$123.0K | -$112.0K | -$112.0K | |
| Increase Decrease In Other Operating Assets | -$5.0K | -$14.0K | |||
| Depreciation Depletion And Amortization | $230.0K | $165.0K | $26.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.72 | -$1.74 | -$1.31 | -$0.65 | -$1.91 | -$1.52 |
| Weighted Average Number Of Shares Outstanding Basic | 53.0M | 31.7M | 28.9M | 28.8M | 18.9M | |
| Weighted Average Number Of Diluted Shares Outstanding | 53.0M | 31.7M | 28.9M | 28.8M | 18.9M | |
| Earnings Per Share Basic | $-0.72 | $-1.74 | $-1.31 | $-0.65 | $-1.91 | |
| Common Stock Shares Outstanding | 54.9M | 46.8M | 29.1M | 28.9M | 28.7M | 11.6M |
| Common Stock Shares Issued | 55.0M | 46.9M | 29.2M | 29.0M | 28.7M | 11.6M |
| Common Stock Shares Authorized | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 75.0M |
| Common Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.21 | -$0.09 | $0.13 | -$0.33 | -$0.74 | -$0.28 | -$0.29 | -$0.33 | -$0.30 | -$0.30 | -$0.14 | -$0.03 | -$0.69 | -$1.46 | -$0.38 | -$0.22 | -$0.25 | ||
| Weighted Average Number Of Shares Outstanding Basic | 54.9M | 51.5M | 50.5M | 32.0M | 29.9M | 29.2M | 28.9M | 28.9M | 28.9M | 28.9M | 28.8M | 28.7M | 23.3M | 11.7M | |||||
| Weighted Average Number Of Diluted Shares Outstanding | 54.9M | 51.5M | 54.8M | 32.0M | 29.9M | 29.2M | 28.9M | 28.9M | 28.9M | 28.9M | 28.8M | 28.7M | 23.3M | 11.7M | |||||
| Earnings Per Share Basic | $-0.21 | $-0.09 | $0.15 | $-0.33 | $-0.74 | $-0.28 | $-0.29 | $-0.33 | $-0.30 | $-0.30 | $-0.14 | $-0.03 | $-0.69 | $-1.46 | |||||
| Common Stock Shares Outstanding | 54.9M | 54.9M | 49.2M | 32.1M | 31.1M | 29.3M | 28.9M | 28.9M | 28.9M | 28.9M | 28.9M | 28.7M | 28.7M | 11.7M | |||||
| Common Stock Shares Issued | 55.0M | 55.0M | 49.4M | 32.2M | 31.2M | 29.5M | 29.0M | 29.0M | 29.0M | 29.0M | 29.0M | 28.7M | 28.7M | 11.7M | |||||
| Common Stock Shares Authorized | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 75.0M | |||||
| Common Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | |||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Preferred Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | ||||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Fair Value Adjustment Of Warrants | -$8.2M | $20.8M | -$966.0K | -$16.4M | $11.4M | $4.6M |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $4.3M | $4.2M | $3.1M | $3.1M | $2.6M | $1.4M |
| Adjustments To Additional Paid In Capital Mark To Market | -$498.0K | $1.1M | -$46.0K | -$838.0K | $375.0K | $695.0K |
| Stock Issued During Period Value Stock Options Exercised | $516.0K | $1.7M | $512.0K | $35.0K | $30.0K | |
| Depreciation | $845.0K | $990.0K | $960.0K | $778.0K | ||
| Capital Expenditures Incurred But Not Yet Paid | $132.0K | $69.0K | $977.0K | |||
| Long Term Loans From Bank | $46.1M | $1.7M | $11.6M | $20.2M | ||
| Interest Paid Net | $1.3M | $1.8M | $2.1M | $1.2M | ||
| Investment Income Net | -$490.0K | -$53.0K | $111.0K | |||
| Stock Issued During Period Value New Issues | $5.0M | $15.8M | $71.3M | |||
| Interest And Other Income | $3.9M | $1.1M | $2.1M | |||
| Stock Issued During Period Shares Stock Options Exercised | 219.8K | 846.9K | 352.6K | 24.4K | 21.4K | |
| Investment Income Interest | $2.1M | $1.2M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fair Value Adjustment Of Warrants | -$1.1M | -$5.7M | -$14.9M | $1.6M | $13.3M | -$7.0K | -$581.0K | -$144.0K | -$724.0K | -$369.0K | -$5.0M | -$8.3M | $8.3M | $12.4M | $507.0K | ||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $1.2M | $1.1M | $798.0K | $1.1M | $1.1M | $1.0M | $735.0K | $746.0K | $798.0K | $757.0K | $724.0K | $828.0K | $1.3M | $819.0K | $431.0K | $83.0K | $83.0K |
| Adjustments To Additional Paid In Capital Mark To Market | $2.0K | -$99.0K | -$484.0K | $110.0K | $733.0K | $13.0K | -$49.0K | -$13.0K | -$65.0K | -$14.0K | -$287.0K | -$335.0K | $595.0K | $250.0K | $220.0K | ||
| Stock Issued During Period Value Stock Options Exercised | $20.0K | $245.0K | $246.0K | $103.0K | $990.0K | $226.0K | $470.0K | $6.0K | $20.0K | $333.0K | $35.0K | ||||||
| Depreciation | $200.0K | $200.0K | $245.0K | $200.0K | $200.0K | $251.0K | $200.0K | $200.0K | $230.0K | ||||||||
| Capital Expenditures Incurred But Not Yet Paid | $16.0K | $0.00 | $66.0K | $421.0K | $1.9M | ||||||||||||
| Long Term Loans From Bank | $0.00 | $0.00 | $0.00 | $4.2M | $6.7M | $9.2M | $14.3M | $16.7M | $19.0M | $20.1M | $20.0M | $19.9M | |||||
| Interest Paid Net | $252.0K | $549.0K | $500.0K | $117.0K | |||||||||||||
| Investment Income Net | -$176.0K | -$365.0K | -$175.0K | -$14.0K | -$15.0K | -$12.0K | $41.0K | $94.0K | |||||||||
| Stock Issued During Period Value New Issues | $4.7M | $384.0K | $4.1M | $3.5M | $186.0K | $71.3M | |||||||||||
| Interest And Other Income | $953.0K | $926.0K | $934.0K | $236.0K | $240.0K | $320.0K | $502.0K | ||||||||||
| Stock Issued During Period Shares Stock Options Exercised | 118.4K | 147.0K | 3.3K | ||||||||||||||
| Investment Income Interest | $240.0K | $320.0K | $502.0K | $453.0K | $711.0K | $343.0K | $70.0K |
Most recent annual filing with the SEC: March 12, 2026
Data sourced from SEC EDGAR public filings as of August 6, 2026.